Table 3.
Variable | Hazard ratio | 95% confidence interval | P valuea |
---|---|---|---|
HCC stage | |||
Stage I or II | 1.000 | 0.069 | |
Stage III or IV | 0.423 | 0.168–1.070 | |
Maximum tumor size | |||
≥3.5 cm | 0.765 | 0.502–1.167 | 0.214 |
<3.5 cm | 1.000 | ||
Tumor number | |||
Single | 1.299 | 0.520–3.244 | 0.576 |
Multiple | 1.000 | ||
IFN therapy after surgery | |||
Yes | 3.054 | 0.745–12.520 | 0.121 |
No | 1.000 | ||
ICGR 15 | |||
≥13.5% | 0.954 | 0.623–1.460 | 0.828 |
<13.5% | 1.000 | ||
Serum albumin level | |||
≥3.8 g/dL | 1.981 | 1.295–3.031 | 0.002 |
<3.8 g/dL | 1.000 | ||
AFP level | |||
≥20 ng/mL | 0.425 | 0.274–0.660 | <0.001 |
<20 ng/mL | 1.000 | ||
Microscopic vascular invasion | |||
Yes | 0.549 | 0.359–0.840 | 0.006 |
No | 1.000 |
OS: overall survival, HCC: hepatocellular carcinoma, IFN: interferon, ICGR 15: indocyanine green retention at 15 min, AFP: alpha-fetoprotein, and aThe Cox proportional hazard model.